The Asymmetry of Glucose
Abstract
Chronic hyperglycemia produces cumulative biochemical stress across multiple physiological systems while offering no compensating benefit.Five independent arguments demonstrate this asymmetry: the body actively opposes sustained elevation through dedicated regulatory machinery; glucose reactivity produces irreversible AGE formation scaling with concentration and duration; mitochondrial substrate overload forces inefficient metabolic pathways generating oxidative stress; chronic elevation converts discrete insulin pulses into continuous noise, corrupting signal fidelity through receptor desensitization; and no natural environment sustained hyperglycemia long enough for adaptive mechanisms to evolve.Each argument establishes cost without corresponding benefit.The directionality holds across all degrees of elevation: movement away from optimal glucose control increases damage without providing advantages.The absence of trade-offs indicates that restoring euglycemia offers pure benefit-a conclusion with significant implications given that dietary patterns in industrialized societies now slant this asymmetry heavily toward harm. ThesisChronic hyperglycemia offers no net physiological upside.While biological systems possess adaptive capacity to manage transient glucose elevations, sustained hyperglycemia produces cumulative biochemical stress across multiple systems: violating homeostatic stability, corrupting molecular integrity, reducing metabolic efficiency, destroying signal fidelity, and creating a state for which no organism was evolutionarily prepared.No compensating benefit exists. DefinitionsChronic hyperglycemia means sustained elevation of blood glucose above the optimal range that healthy organisms actively maintain, persisting for substantial portions of each day over weeks to months.This excludes several physiological states that superficially resemble hyperglycemia: postprandial
Fields of Study & Subjects
Diabetes Management and Research
Pancreatic function and diabetes
Cancer and biochemical research
Publication details
- Publication date
- 8 January 2026
- Document type
- Preprint